CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total revenue	$ 35,972	$ 12,816
Total cost of goods and services	20,668	5,886
Gross margin	15,304	6,930
Operating expenses:
Sales and marketing	2,726	885
Research and development	1,587	1,570
General and administrative	13,659	3,723
Depreciation and amortization	5,236	904
Stock-based compensation	1,374	0
Lease abandonment expenses	75	0
Goodwill and intangible asset impairment	6,174	0
Acquisition, integration, and transformation costs	2,384	2,686
Total operating expenses	33,215	9,768
Loss from operations	(17,911)	(2,838)
Other income (expense):
Interest expense	(6,995)	(711)
Gain on consolidation of equity method investment	0	640
Gain on fair value of derivative liability	4,829	0
Gain on fair value of warrant liabilities	95	0
Other income (expense), net, including interest income	(16)	37
Total other expense	(2,087)	(34)
Loss before income tax benefit	(19,998)	(2,872)
Income tax benefit	2,293	406
Net loss before loss from equity method investment	(17,705)	(2,466)
Loss from equity method investment	0	(561)
Net loss	(17,705)	(3,027)
Less: net income (loss) attributable to noncontrolling interests	(260)	(78)
Net loss attributable to UpHealth, Inc.	$ (17,445)	$ (2,949)
Net loss per share attributable to UpHealth, Inc.:
Basic (in dollars per share)	$ (0.12)	$ (0.42)
Diluted (in dollars per share)	$ (0.12)	$ (0.42)
Weighted average shares outstanding:
Basic (in shares)	144,539	7,089
Diluted (in shares)	144,539	7,089
Services
Total revenue	$ 25,686	$ 8,138
Total cost of goods and services	14,445	4,473
Licenses and subscriptions
Total revenue	1,781	3,658
Total cost of goods and services	233	497
Products
Total revenue	8,505	1,020
Total cost of goods and services	$ 5,990	$ 916